| 1. |
Kim HD, Hwang SM, Lim KR, et al. Recurrent auricular keloids during pregnancy. Arch Plast Surg, 2013, 40(1): 70-72..
|
| 2. |
Mauviel A. Transforming growth factor-beta: a key mediator of fibrosis. Methods Mol Med, 2005, 117: 69-80.
|
| 3. |
陳勇, 戴和平, 龍志高, 等.人皮膚成纖維細胞的分離和體外培養.湖南醫科大學學報, 2002, 27(5): 477-478.
|
| 4. |
夏鵬, 童文祥, 喻永敏, 等.大鼠皮膚切創愈合過程中VEGF, TGF-β蛋白的表達.重慶醫科大學學報, 2010, 35(8): l167-1171.
|
| 5. |
Liang CJ, Yen YH, Hung LY, et al. Thalidomide inhibits fibronectin production in TGF-β1-treated normal and keloid fibroblasts via inhibition of the p38/Smad3 pathway. Biochem Pharmacol, 2013, 85(11): 1594-1602.
|
| 6. |
Wu CS, Wu PH, Fang AH, et al. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach. Br J Dermatol, 2012, 167(3): 532-541.
|
| 7. |
Kottler UB, Jünemann AG, Aigner T, et al. Comparative effects of TGF-beta 1 and TGF-beta 2 on extracellular matrix production, proliferation, migration, and collagen contraction of human Tenon's capsule fibroblasts in pseudoexfoliation and primary open-angle glaucoma. Exp Eye Res, 2005, 80(1): 121-134.
|
| 8. |
Chang Z, Kishimoto Y, Hasan A, et al. TGF-β3 modulates the inflammatory environment and reduces scar formation following vocal fold mucosal injury in ruts. Dis Model Mech, 2013, 7(1): 83-91.
|
| 9. |
Falk P, Angenete E, Bergstrom M, et al. TGF-β1 promotes transition of mesothelial cells into fibroblast phenotype in response to peritoneal injury in a cell culture model. Int J Surg, 2013, 11(9): 977-982.
|
| 10. |
Attisanno L, Wrana JL. Signal transduction by the TGF-beta superfamily. Science, 2002, 296(5573): 1646-1647.
|
| 11. |
ten Dijke P, Miyazono K, Heldin CH. Signaling inputs converge on nuclear effectors in TGF-βsignaling. Trends Biochem Sci, 2000, 25(2): 64-70.
|
| 12. |
李春輝, 潘理會, 張德利.胃癌組織TGF-β、Smad7與ki-67 mRNA表達及其相關性分析.實用醫學雜志, 2014, 30(5): 751-754.
|
| 13. |
Yu F, Guo Y, Chen B, et al. MicroRNA-17-5p activates hepatic stellate cells through targeting of Smad7. Lab Invest, 2015, 95(7): 781-789.
|
| 14. |
Brodin G, ten Dijke P, Funa K, et al. Increased Smad expression and activation is associated with apoptosis in normal and malignant prostate after castration. Cancer Res, 1999, 59(11): 2731-2738.
|
| 15. |
Landstr?m M, Heldin NE, Bu S, et al. Smad7 mediates apoptosis induced by transforming growth factorβin prostatic carcinoma cells. Curr Biol, 2000, 10(9): 535-538.
|
| 16. |
Kamato D, Burch M, Piva TJ, et al. Transforming growth factor-βsignalling:Role and consequences of Smad linker region phosphorylation. Cells Signal, 2013, 25(10): 2017-2024.
|
| 17. |
Ladin DA, Hou L, Patel D, et al. P53 and apoptosis alterations in keloids and keloid fibroblasts. Wound Repair Regen, 1998, 6(1): 28-37.
|
| 18. |
Appleton I, Brown NJ, Willoughby DA. Apoptosis, necrosis, and proliferation:possible implications in the etiology of keloid. Am J Pathol, 1996, 149(5): 1441-1447.
|
| 19. |
Crowston JG, Chang LH, Constable PH, et al. Apoptosis gene expression and death receptor signaling in mitomycin-C-treated human tenon capsule fibroblasts. Invest Ophthalmol Vis Sci, 2002, 43(3): 692-699.
|
| 20. |
劉永波, 高建華, 段紅杰, 等.瘢痕疙瘩p53基因突變高發區基因結構的研究.中華整形外科雜志, 2003, 19(4): 258-260.
|